2016 Faculty

As of September 1, 2016

Aaron Day-Williams, Ph.D., Biogen Scientific Lead, Open Targets; Associate Director and Head, Statistical Genetics, Biogen

Aashish Manglik, M.D., Ph.D., Stanford Distinguished Fellow, Department of Molecular and Cellular Physiology, Stanford University

Abraham Scaria, Ph.D., Senior Scientific Director, Ophthalmology, Genzyme, a Sanofi Company

Adam Weinglass, Ph.D., Director, Cell Pharmacology, In Vitro Pharmacology, Merck Research Laboratories

Adrien Nivoliez, Ph.D., General Manager R&D, biose®

Alan P. Kozikowski, Ph.D., Professor, College of Pharmacy, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago and Actuate Therapeutics Inc.

Alan V. Smrcka, Ph.D., Professor, Pharmacology and Physiology, University of Rochester School of Medicine

Alessio Ciulli, Ph.D., Associate Professor, Chemical & Structural Biology, School of Life Sciences, University of Dundee

Alexander Bassuk, M.D., Ph.D., Associate Professor of Pediatrics, Department of Molecular and Cellular Biology, University of Iowa

Alexander Gragerov, Ph.D., Senior Director of Research, Discovery, Omeros Corp.

Alexander Statsyuk, Ph.D., Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston

Ali Ashkar, D.V.M., Ph.D., Professor, Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University

Amar Thyagarajan, Ph.D., Associate Director Product Marketing, Crown Bioscience

Ananda Chakrabarty, Ph.D., Department of Microbiology & Immunology, University of Illinois College of Medicine

Anastasia Wyce, Ph.D., Investigator, R&D Oncology, GlaxoSmithKline

Anatoly Shcherbatko, Ph.D., Associate Research Fellow, Rinat Laboratories, Pfizer, Inc.

Andras Perl, M.D., Ph.D., Professor of Microbiology and Immunology, Chief, Division of Rheumatology, State University of New York, UMU, College of Medicine

Andrew Alt, Ph.D., Senior Research Investigator, Lead Discovery, Bristol-Myers Squibb

Andrew Conery, Ph.D., Senior Scientist II, Constellation Pharmaceuticals

Andrew Nixon, Ph.D., Independent Consultant

Andrew Phillips, Ph.D., CSO, C4 Therapeutics

Andrew Tebben, Ph.D., Senior Principal Scientist, Molecular Structure and Design, Bristol Myers Squibb Co.

Anne Robinson, Ph.D., Professor and Chair, Chemical & Biomolecular Engineering, Tulane University

Annette Gilchrist, Ph.D., Professor, Pharmacology, Midwestern University

Antonio Marchini, Ph.D., Principal Investigator, Tumor Virology Division, German Cancer Research Center (DKFZ)

Anu Daniel, Ph.D., Licensing Manager, Innovation, Partners Healthcare

Arthur L. Shaffer, III, Ph.D., Staff Scientist, Laboratory of Dr. Louis Staudt, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Arvind Rao, Ph.D., Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center

Aylin Hanyaloglu, Ph.D., Senior Lecturer, Institute of Reproductive and Developmental Biology, Imperial College London

Bahram (Bob) Valamehr, Ph.D., MBA, Executive Director, Reprogramming Biology, Fate Therapeutics Inc.

Barbara Wirostko, M.D., CMO, EyeGate Pharmaceuticals, Inc.

Barry Bunin, Ph.D., CEO, Collaborative Drug Discovery

Bart Staels, Ph.D., Professor, INSERM, University of Lille, Pasteur Institute

Benedikt Kessler, Ph.D., Professor, Biochemistry and Life Science Mass Spectrometry, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford

Benjamin Housden, Ph.D., Post-Doctoral Fellow, Laboratory of Dr. Norbert Perrimon, Department of Genetics, Harvard Medical School

Benjamin Stanton, Ph.D., Research Associate, Laboratory of Dr. Gerald Crabtree, Stanford University School of Medicine and Howard Hughes Medical Institute; Laboratory of Dr. Keji Zhao, Laboratory of Epigenome Biology, NHLBI, National Institutes of Health

Berkley A. Lynch, Ph.D., Senior Director, CNS Research, Rodin Therapeutics

Berkley E. Gryder, Ph.D., Research Scientist, Laboratory of Dr. Javed Khan, Genetics Branch, National Cancer Institute, National Institutes of Health

Bernat Olle, Ph.D., CEO, Vedanta Biosciences, Inc.

Bonnie Feldman, D.D.S., MBA, Digital Health Analyst and Chief Growth Officer, DrBonnie360

Brian Cathers, Ph.D., Executive Director, Co-Leader & Head, Drug Discovery, Protein Homeostasis Thematic Center of Excellence, Celgene

Brian Hodous, Ph.D., Director, Medicinal Chemistry, Blueprint Medicines

Bruno Marchon, Ph.D., CTO, EpiBiome

Bryan R. Cullen, Ph.D., James B. Duke Professor of Molecular Genetics and Microbiology and Director, Center for Virology, Duke University

Cameron Wheeler, Ph.D., Principal, Deerfield Management 

Campbell McInnes, Ph.D., Associate Professor, Drug Discovery & Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina

Charles P. Venditti, M.D., Ph.D., Head, Organic Acid Research Section, Senior Investigator, National Human Genome Research Institute, National Institutes of Health

Cheryl H. Cui, Ph.D. Candidate, Harvard-MIT Division of Health Science and Technology, MIT

Christian Hinderer, Ph.D., Post-Doctoral Fellow, Laboratory of Dr. James Wilson, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania

Christine Seidl, Ph.D., Post-Doctoral Research Associate, Cell Signaling, Kennedy Institute of Rheumatology, Oxford University

Christopher Gibson, Ph.D., Co-Founder and CEO, Recursion Pharmaceuticals LLC

Christopher Koth, Ph.D., Senior Scientist, Structural Biology, Genentech

Chun-Liang Chen, Ph.D., Assistant Professor, Molecular Medicine, University of Texas Health Science Center at San Antonio

Chun-Ming Eric Huang, Ph.D., Professor, Division of Dermatology, University of California San Diego

Ciro Bonetti, Ph.D., Postdoctoral Scientist, Laboratory of Dr. Andrea Ventura, Memorial Sloan-Kettering Cancer Center

Claes Wahlestedt, M.D., Ph.D., Leonard M. Miller Professor & Associate Dean, Therapeutic Innovation, Miller School of Medicine, University of Miami

Clare Thibodeaux, Ph.D., Director of Scientific Affairs, Cures Within Reach

Clary B. Clish, Ph.D., Director, Metabolite Profiling, Broad Institute of MIT and Harvard

Colin Nichols, Ph.D., Carl Cori Professor in Cell Biology and Physiology, and Director of the Center for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine

Corey R. Hopkins, Ph.D., Associate Professor, Department of Pharmaceutical Sciences, University of Nebraska Medical Center 

Craig M. Crews, Ph.D., Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology; Professor, Chemistry & Pharmacology, Yale University

Daniel Anderson, Ph.D., Professor, Department of Chemical Engineering, Institute for Medical Engineering & Science, Harvard-MIT Division of Health Sciences & Technology and David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Daniel Finley, Ph.D., Professor, Cell Biology, Harvard Medical School

Daniel Mattle, Ph.D., Roche Postdoctoral Research Fellow, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel

Daniel Treiber, Ph.D., Vice President, KINOMEscan, DiscoverX Corporation

David Berry, M.D., Ph.D., General Partner, Flagship Ventures

David Fellows, CEO, NightstaRx

David Kyle, CEO, Evolve Biosystems, Inc.

David M. Kranz, Ph.D., Professor, Biochemistry, University of Illinois, Urbana-Champaign

David Pearlman, Ph.D., Senior Principal Scientist, Schrödinger

David R. Buckler, Ph.D., Director, Therapeutic Proteins, Regeneron Pharmaceuticals

David T.S. Hayman, Ph.D., Senior Lecturer in Veterinary Public Health, Co-Director, mEpiLab, OIE Collaborating Centre Infectious Disease Research Centre, Hopkirk Research Institute, Massey University, New Zealand

David Thomas, Ph.D., Chair and Professor, Biochemistry, McGill University

Dean Anthony Lee, M.D., Ph.D., Professor, Pediatrics; Director, Cellular Therapy and Cancer Immunotherapy Program, Nationwide Children’s Hospital; James Comprehensive Cancer Center/Solove Research Institute, The Ohio State University

Dean Scholl, Ph.D., Director of Research, AvidBiotics Corporation

Deborah Dodge, Senior Scientist, Ensemble Therapeutics

Debra T. Hansen, Ph.D., Associate Research Professor, Center for Applied Structural Discovery, Arizona State University

Deepak K. Rajpal, D.V.M., Ph.D., Director, Computational Biology, GlaxoSmithKline

Diana Ronai Dunshee, Ph.D., Department of Molecular Biology, Senior Scientific Researcher, Genentech, Inc.

Dimitrios Iliopoulos, Ph.D., MBA, Professor, David Geffen School of Medicine and Founding Director, Center for Systems Biomedicine, University of California at Los Angeles

Dimitrios Spiliotopoulos, Ph.D., SNF SystemsX.ch Postdoctoral Fellow, Department of Biochemistry, University of Zurich

Dominique Verhelle, Ph.D., MBA, Strategic Advisor, Third Rock Ventures

Donald Zack, M.D., Ph.D., Guerrieri Professor of Genetic Engineering and Molecular Ophthalmology, Johns Hopkins University

Doriano Fabbro, Ph.D., CSO, PIQUR Therapeutics

Dustin McMinn, Ph.D., Director, Head of Medicinal Chemistry, Kezar Life Sciences, Inc.

Edward Driggers, CSO, General Metabolics

Edward Holson, Ph.D., CSO, KDAc Therapeutics

Edward Seto, Ph.D., Professor, Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, George Washington University

Einar Stefansson, M.D., Ph.D., FARVO, Chairman, Co-Founder, Oculis

Elisabeth Martinez, Ph.D., Assistant Professor, Pharmacology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center

Elizaveta Freinkman, Ph.D., Research Scientist and Manager, Metabolite Profiling Facility, Whitehead Institute, MIT

Emad Tajkhorshid, Ph.D., Professor, Biophysics, Biochemistry, and Pharmacology, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign

Eric Grazzini, Ph.D., Team Leader Rapid Protein Production, Senior Research Officer, Biologics, National Research Council of Canada, Canada

Eugen Buehler, Ph.D., Group Leader, Informatics, National Center for Advancing Translational Sciences, National Institutes of Health

Eytan M. Stein, M.D., Assistant Attending Physician, Department of Medicine, Memorial Sloan Kettering Cancer Center

Florence Fevrier-Wagner, Ph.D., Senior Group Leader, Medicinal Chemistry, Stanley Center for Psychiatric Research, Broad Institute

Francesco Parlati, Ph.D., Senior Director, Biology, Calithera Biosciences

Frank Lovering, Ph.D., Associate Research Fellow, World Wide Medicinal Chemistry, Pfizer 

Gang Xing, Ph.D., Principal Scientist, CVMET Department, Pfizer Biomedical Institute

Gayathri Swaminath, Ph.D., Principal Scientist, Metabolic Disorders, Amgen

Gebhard F.X. Schertler, Ph.D., Professor, Head of Biology and Chemistry, Paul Scherrer Institute

Geoffrey Bartholomeusz, Ph.D., Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Georg K. Gerber, M.D., Ph.D., MPH, Assistant Professor of Pathology, Harvard Medical School; Co-Director, Massachusetts Host-Microbiome Center; Associate Pathologist, Brigham and Women’s Hospital Center for Advanced Molecular Diagnostics

Georges Grinstein, Ph.D., Professor Emeritus, Computer Science Department and Director, Institute for Visualization and Perception Research, University of Massachusetts Lowell; Chief Science Officer, Weave Visual Analytics

Gerald Gavory, Ph.D., Director, Head of Biology, Almac Discovery

Gerard Honig, Ph.D., Founder & CEO, Symbiotic Health, Inc.

Greg Sieczkiewicz, J.D., Ph.D., Chief IP Council, MPM 

Gregory Ducker, Ph.D., Postdoctoral Research Fellow, Rabinowitz Laboratory, Princeton University

Gregory L. Verdine, Ph.D., Erving Professor, Chemistry, Departments of Stem Cell and Regenerative Biology, Chemistry and Chemical Biology, and Molecular and Cellular Biology, Harvard University and Harvard Medical School

Guido J.R. Zaman, Ph.D., Managing Director & Head of Biology, Netherlands Translational Research Center B.V. (NTRC)

H. Eric Xu, Ph.D.,Professor, Cancer Research, Van Andel Institute (VAI)

H. James Harwood, Ph.D., Delphi BioMedical Consultants, LLC

Hans Hofland, Ph.D., Vice President Research and Nonclinical Development, Dermira, Inc.

Hans Klingemann, M.D., Ph.D., Vice President, Research & Development, NantKwest, Inc.

Haruki Hasegawa, Ph.D., Principal Scientist, Therapeutic Discovery - Biologics, Amgen, Inc.

Heidi Hamm, Ph.D., Professor, Department of Pharmacology, Vanderbilt University Medical Center

Henk-Jan Joosten, Ph.D., CEO, Bio-Prodict

Hicham Zegzouti, Ph.D., Senior Research Scientist, Research and Development, Cellular and Biochemical Technologies, Promega Corporation

Hongkai Zhang, Ph.D., Senior Scientist, Lerner Laboratory, The Scripps Research Institute

Ingrid E. Wertz, M.D., Ph.D., Senior Scientist, Discovery Oncology and Early Discovery Biochemistry, Genentech, Inc.

Irfan A. Asangani, Ph.D., Assistant Professor, Cancer Biology, Perelman School of Medicine, University of Pennsylvania

Irina Klimanskaya, Ph.D., Senior Director of Translational Development, Astellas Institute for Regenerative Medicine (AIRM)

Irina Kufareva, Ph.D., Project Scientist, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego

Istvan Enyedy, Ph.D., Senior Scientist, Drug Discovery, Biogen

J. Christopher Love, Ph.D., Associate Member, Broad Institute; Associate Professor, Chemical Engineering, Koch Institute for Integrative Cancer Research at MIT; and Associate Member, Ragon Institute of MGH, MIT, and Harvard

Jack Leonard, Ph.D., Professor, Microbiology and Physiological Systems, UMASS Medical School

Jack Taunton, Ph.D., Professor, Cellular and Molecular Pharmacology, UCSF School of Medicine, University of California, San Francisco

James Inglese, Ph.D., Head Assay Development & Screening Technologies, National Center for Advancing Translational Sciences, National Institutes of Health

James S. Baldassarre, M.D., Head, Clinical Development, Janssen

James Wilson, M.D., Ph.D., Professor, Department of Pathology and Laboratory Medicine, Perelman School of Medicine; Director, Orphan Disease Center and Director, Gene Therapy Program, University of Pennsylvania

Jan Spanholtz, Ph.D., CSO, Glycostem Therapeutics

Jan Steyaert, Ph.D., Vice-Director, Structural Biology Research Center, Vlaams Instituut voor Biotechnologie and Senior Advisor, ConFoTherapeutics

Jason Slakter, CEO, Ohr Pharmaceutical, Inc.

Jay D. Horton, M.D., Professor, Internal Medicine and Molecular Genetics; Chair, Obesity and Diabetes; Chief of Division of Digestive and Liver Diseases, UT Southwestern Medical Center

Jean de Gunzburg, Ph.D., CSO, Da Volterra

Jeff MacKeigan, Ph.D., Associate Professor, Innovation and Integration Program, Center for Cancer and Cell Biology, Van Andel Research Institute

Jeffery G. Saven, Ph.D., Professor, Chemistry, University of Pennsylvania

Jeffrey Barrett, D.Phil., Founding Director, Open Targets; Group Leader, Wellcome Trust Sanger Institute

Jeffrey L. Benovic, Ph.D., Professor and Chair, Department of Biochemistry & Molecular Biology, Thomas Jefferson University

Jeffrey Miller, M.D., Professor, Medicine; Deputy Director, Masonic Cancer Center; Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics, University of Minnesota

Jens Frauenfeld, Ph.D., CEO, Salipro Biotech AB, Sweden

Jessica R. Allegretti, M.D., MPH, Attending Gastroenterologist, Director of Clinical Trials and Director of the Fecal Transplant Program for Recurrent Clostridium Difficile, Brigham and Women’s Hospital Crohn’s and Colitis Center

Jing Liu, Ph.D., Assistant Professor, Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai

John “Jay” Schneekloth Jr., Ph.D., Investigator, Chemical Biology Laboratory; Head, Chemical Genetics Section, Center for Cancer Research, National Cancer Institute, NIH

John Burg, Ph.D., Head, Biochemistry, Ab Initio Biotherapeutics

John Hambor, Ph.D., Director, Research Beyond Borders, Boehringer Ingelheim

John Kenney, Ph.D., President, Antibody Solutions

John Kurhanewicz, Ph.D., Professor, Pharmaceutical Chemistry, University of California San Francisco

John M. Conley, J.D., Ph.D., William Rand Kenan, Jr. Professor of Law, University of North Carolina, Chapel Hill; Counsel, Robinson Bradshaw & Hinson

Jonas Nilsson, Ph.D., Professor, Experimental Cancer Surgery, Surgery, Sahlgrenska Cancer Center, University of Gothenburg

Jonathan Ellery, Ph.D., Director, Pharmacology, Takeda

Joseph Rucker, Ph.D., Vice President, Research and Development, Integral Molecular, Inc.

JT Koerber, Ph.D., Scientist, Antibody Engineering, Genentech

Julen Oyarzabal, Ph.D., Director, Translational Sciences, Center for Applied Medical Research (CIMA), University of Navarra

Junwei Shi, Ph.D., Assistant Professor, Department of Cancer Biology, University of Pennsylvania School of Medicine

Justin Hanes, Ph.D., Lewis J. Ort Professor; Director, The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine; Founder, Kala Pharmaceuticals and GrayBug Vision

Kamal Puri, Ph.D., Director, Immunology & Inflammation, Celgene Corp.

Kamyar Hadian, Ph.D., Principal Investigator & Head, Assay Development and Screening Platform, HelmholtzZentrum München

Kang Zhang, M.D., Ph.D., Professor of Ophthalmology, Chief of Ophthalmic Genetics at University of California San Diego

Karl-Johan Malmberg, M.D., Ph.D., Professor, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital

Katerina Kuznetsova, Ph.D., Research Scientist, Reaction Biology Corporation

Keith F. Batchelder, M.D., CEO and Founder, Genomic Healthcare Strategies 

Keith R. Jerome, M.D., Ph.D., Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Professor and Head, Virology Division, Department of Laboratory Medicine, University of Washington

Kelsey Achenbach, Strategic Marketing Manager, Healthcare, Celanese

Ken Mandell, President and CEO, LayerBio, Inc.

Kevin Xiang, Ph.D., Professor, Pharmacology, University of California Davis

Kirk Beebe, Ph.D., Director, Application Science, Metabolon

Kiyoshi Takayama, Ph.D., President, Research Center, NB Health Laboratory Co., Ltd., Japan

Klaus Gottlieb, M.D., FACG, Vice President, Clinical & Regulatory Affairs, Synthetic Biologics, Inc.

Konrad Kauper, MSc, Vice President, Core Technology Development, Neurotech Pharmaceuticals, Inc.

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

Kristi Leonard, Ph.D., Associate Scientific Director, Immunology Research, Janssen Research & Development

Laetitia Martin, Ph.D., Research Laboratory Head & Project Leader, Medicinal Chemistry, Boehringer Ingelheim

Larry Weiss, M.D., CMO, AOBiome, LLC

Laura M. Bohn, Ph.D., Professor, Departments of Molecular Therapeutics & Neuroscience, The Scripps Research Institute

Lee Kaplan, M.D., Ph.D., Director, Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, Harvard Medical School

Lili Huang, M.D., Ph.D., Principal Research Scientist, AbbVie

Lindsey Ingerman James, Ph.D., Research Assistant Professor, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Lisa Minor, Ph.D., Business Development Consultant, Multispan, Inc.

Lita M. Proctor, Ph.D., Coordinator, NIH Human Microbiome Project 

Liz Carpenter, Ph.D., Professor, Structural Genomics Consortium, Oxford University, United Kingdom

Lyn Jones, Ph.D., Head of Rare Diseases Chemistry and Chemical Biology Group Leader, Pfizer Worldwide Medicinal Chemistry

M. Joyce Rico, M.D., MBA, Chief Medical Officer, Novan, Inc.

Margaret S. Lee, Ph.D., Vice President, Research & Translational Development, Karyopharm Therapeutics, Inc.

Mark Albertella, D.Phil., Director, Biology, Medivir

Martin J. Scott, Ph.D., Investigator, Biopharm Molecular Discovery, GlaxoSmithKline, United Kingdom

Martin Michel, Ph.D. Candidate - MRC Laboratory, Molecular Biology, University of Cambridge

Martine Morrison, Ph.D., Research Scientist, Metabolic Health Research, The Netherlands Organization of Applied Scientific Research (TNO)

Masanori Aikawa, M.D., Ph.D., Director, Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women’s Hospital and Associate Professor of Medicine, Harvard Medical School

Masoud Vedadi, Ph.D., Principal Investigator, Molecular Biophysics, Structural Genomics Consortium; Assistant Professor, Department of Pharmacology and Toxicology, University of Toronto

Matt Adams, Vice President, Technical Operations and Business Development, Rebiotix

Matthew Eddy, Ph.D., Postdoctoral Fellow, Ray Stevens Laboratory, The Bridge Institute, University of Southern California

Matthew Fell, Ph.D., Associate Principal Scientist, Early Neuroscience Discovery, Merck Research Laboratories 

Matthew Gardener, Ph.D., Senior Scientist, ADPE, MedImmune, United Kingdom

Matthew Jarpe, Ph.D., Associate Vice President of Biology, Acetylon Pharmaceuticals

Meera Kumar, M.S., Senior Applications Scientist, Research & Development, BellBrook Labs

Meng Zhou, Head, R&D, Contract Pharmaceutical Limited Canada

Michael Byrne, Ph.D., Director, Pharmacology, RXi Pharmaceuticals

Michael Gallo, Ph.D., President, Research, Innovative Targeting Solutions Inc.

Michael Hust, Ph.D., Professor, Department of Biotechnology, Technische Universität Braunschweig

Michael Mullin, Ph.D., Investigator, Protein Cellular and Structural Sciences, RD Platform Technology and Science, GlaxoSmithKline, United Kingdom

Michael Pacold, Ph.D., Postdoctoral Research Fellow, Sabitini Lab, MIT

Michael Sierra, Ph.D., Vice President, Head, LEO Science & Tech Hub USA, LEO Pharma

Mick Foley, Ph.D., CSO, Biochemistry, AdAlta, Australia

Mike Milburn, Ph.D., CSO, Metabolon

Minkui Luo, Ph.D., Associate Member & Associate Professor, Chemical Biology Program, Memorial Sloan Kettering Cancer Center

Mitchell Brigell, Ph.D., Vice President, Clinical Development, Aerpio Therapeutics

Naj Sharif, Ph.D., FARVO, Executive Director and Head, Global Alliances & External Research, Santen, Inc.

Namjin Chung, Ph.D., Head, Functional Genomics Platform, Discovery Research, AbbVie, Inc.

Nathaniel Roquet, Ph.D. Graduate Student, Harvard Biophysics Program; Synthetic Biology Group (Professor Timothy Lu), Massachusetts Institute of Technology

Neville Sanjana, Ph.D., Core Faculty Member, New York Genome Center and Assistant Professor, Department of Biology & Center for Genomics and Systems Biology, New York University

Niels Klitgord, Ph.D., Bioinformatician, Human Longevity, Inc.

Nils Gehlenborg, Ph.D., Assistant Professor, Department of Biomedical Informatics, Harvard Medical School

Nir Qvit, Ph.D., Postdoctoral Fellow, Department of Chemical and Systems Biology, Stanford University

Norman C.W. Wong, M.D., FRCPC, Professor of Medicine and Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary; CSO & Co-Founder, Resverlogix

Oleg Fedorov, Ph.D., Group Leader, Biophysics and Biochemical Screening, Structural Genomics Consortium and Target Discovery Institute, University of Oxford

Olena Barbash, Ph.D., Investigator, Oncology R&D, GlaxoSmithKline

Pamela Munster, M.D., Professor, Department of Medicine; Director, Early Phase Clinical Trials Unit, and Leader, Developmental Therapeutics Program, University of California San Francisco

Patricia Maciel, Ph.D., Associate Professor and Senior Researcher at the School of Health Sciences of the University of Minho, Braga, Portugal

Patricia McDonald, Ph.D., Associate Scientific Director, Translational Research Institute, The Scripps Research Institute

Paul C. Trippier, Ph.D., Assistant Professor in Pharmaceutical Sciences at the Texas Tech University Health Sciences Center School of Pharmacy

Paul Enríquez, J.D., LL.M., Ph.D. Candidate, Structural and Molecular Biochemistry, North Carolina State University

Paul Galatsis, Ph.D., Senior Principal Scientist, Worldwide Medicinal Chemistry, Pfizer

Paul Insel, M.D., Distinguished Professor, Pharmacology and Medicine, University of California San Diego

Paul M. Bingham, Ph.D., Vice President, Research, Cornerstone Pharmaceuticals and Professor, Biochemistry and Cell Biology, Stony Brook University

Paul Wylie, Ph.D., Head, Applications, TTP Labtech

Peter Juhasz, Ph.D., Director, Mechanisms and Pathways, Biogen

Peter Ordentlich, Ph.D., CTO and Founder, Syndax Pharmaceuticals

Phil Zaworski, MS, Senior Research Scientist, Biochemistry, PharmOptima LLC

Phillip Liu, Ph.D., Associate Director, Applied Technology, Incyte Corporation

Phil Strandwitz, Ph.D., Postdoctoral Research Associate, The Lewis Lab, Northeastern University Antimicrobial Discovery Center

Pravien Abeywickrema, Associate Principal Scientist, Screening and Protein Sciences, Merck & Co., Inc.

R. Michael Burr, MS, MBA, Vice President, Product Development, iVeena, Inc.

Rachel Salzman, DVM, CSO, The Stop ALD Foundation

Raju Pusapati, Ph.D., Scientist, Ribon Therapeutics; formerly Postdoctoral Research Fellow, Discovery Oncology, Genentech

Ralph Garippa, Ph.D., Director, RNAi & Gene Editing Core Facility, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center

Ralph Mazitschek, Ph.D., Assistant Professor, Harvard Medical School and Co-Director of the Chemical Biology Platform, Center for Systems Biology, Massachusetts General Hospital

Randal Eckert, Ph.D., Senior Director, Preclinical Biology, C3 Jian, Inc.

Rebecca Taub, M.D., Ph.D., CEO, Madrigal Pharmaceuticals

Richard Hopkinson, Ph.D., Research Fellow, Schofield Group, Chemistry Research Laboratory, Department of Chemistry, University of Oxford

Richard Isaacs, Ph.D., Applied Research Sciences Manager, Molecular Sensing, Inc.

Ricky Johnstone, Ph.D., Assistant Director of Research Division; Co-Head, Cancer Therapeutics Program and Head - Gene Regulation Laboratory, Peter MacCallum Cancer Centre, Australia

Robert A. Baiocchi, M.D., Ph.D., Associate Professor, Division of Hematology, Department of Internal Medicine, The Ohio State University

Robert Hughes, Ph.D., Senior Associate Director, Small Molecule Discovery Research, Boehringer-Ingelheim

Roderick Beijersbergen, Ph.D., Group Leader, Netherlands Cancer Institute and Head, NKI Robotics and Screening Center

Roger Bosse, Ph.D., Senior Market Segment Leader, PerkinElmer

Roger Dawson, Ph.D., Principal Scientist, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Switzerland

Rohit Duggal, Ph.D., Director, Experimental Cellular Therapy, Sorrento Therapeutics

Roland Grenningloh, Ph.D., Director, Preclinical Pharmacology, EMD Serono

Ron Dror, Ph.D., Associate Professor of Computer Science and, by courtesy, Molecular and Cellular Physiology, Stanford University

Ron Lahav, Ph.D., CEO, ART Bioscience Ltd.

Rory Curtis, Ph.D., Vice President & Site Head, AMRI Buffalo, Discovery & Development, AMRI

Ross Chambers, Ph.D., Director, Antibody Discovery, Integral Molecular, Inc.

Ryan Potts, Ph.D., Associate Member, Faculty, Cell & Molecular Biology, St. Jude Children’s Research Hospital

Ryan Raver, Ph.D., Global Product Manager, Functional Genomics, MilliporeSigma

Sacha Mann, CEO, Immune Product Services Ltd and Venture Partner, Inventages

Sai Pulukuri, Ph.D., Senior Scientist & Project Team Leader, Millennium: The Takeda Oncology Company

Samantha J. Allen, Ph.D., Senior Scientist, Emerging Science& Innovation, Janssen Research Labs

Sanath Meegalla, Ph.D., Principal Scientist, Cardiovascular and Metabolic Therapeutic Area, Janssen Research & Development, LLC

Sang Hyun Lee, Ph.D., Principal Scientist, Pharmacology, Incyte Corporation

Satinder Kaur Singh, Ph.D., Assistant Professor, Cellular & Molecular Physiology, Yale University School of Medicine

Scott Cowen, Ph.D., Discovery Sciences, AstraZeneca R&D Boston

Scott Martin, Ph.D., Group Lead, Functional Genomics, Genentech Inc.

Scott Ribich, Ph.D., Associate Director, Biological Sciences, Epizyme

Sean Ainsworth, CEO, RetroSense

Seng-Lai “Thomas” Tan, Ph.D., Senior Director and Head of Immunology, Forma Therapeutics

Shaomeng Wang, Ph.D., Warner-Lambert/Parke-Davis Professor, Medicine; Professor, Medicine, Pharmacology and Medicinal Chemistry; Director, Center for Therapeutics Innovation, University of Michigan

Shaun Stauffer, Ph.D., Research Assistant Professor, Pharmacology; Associate Director, Medicinal Chemistry, Vanderbilt University

Sheng Bin Peng, Ph.D., Group Leader and Senior Research Advisor, Eli Lilly & Co.

Shilpi Arora, Ph.D., Senior Scientist, Biology, Constellation Pharmaceuticals

Shuqian Jing, Ph.D., Founder and CEO, Gmax Biopharm, LLC, China

Simone T. Sredni, M.D., Ph.D., Research Assistant Professor, Neurological Surgery, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago

Sotirios Koutsopoulos, Ph.D., Research Scientist, Center for Biomedical Engineering, Massachusetts Institute of Technology

Stephanos Ioannidis, Ph.D., Director, Medicinal Chemistry, FORMA Therapeutics

Stephen F. Previs, Ph.D., Senior Scientist, Translational Biomarker - CardioMetabolic Disease, Merck & Co.

Stephen Shuttleworth, Ph.D., FRSC, CChem, CSO, Karus Therapeutics Ltd.

Steven Charlton, Ph.D., Professor, Molecular Pharmacology, University of Nottingham

Sujata Sharma, Ph.D., Director, Screening and Protein Science, Merck and Company

Susan Kling Finston, J.D./M.P.P., CEO, Amrita Therapeutics Ltd.

Suvit Thaisrivongs, Ph.D., Head of Immunoscience Chemistry, Pfizer Worldwide R&D

Tamara Maes, Ph.D., Co-Founder, Vice President & CSO, Oryzon Genomics S.A.

Tania Konry, Ph.D., Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University

Tatiana Kutateladze, Ph.D., Professor, Department of Pharmacology, Anschutz Medical Campus, University of Colorado

Tauseef R. Butt, Ph.D., President and CEO, Progenra, Inc.

Terry Crawford, Senior Scientific Researcher, Medicinal Chemistry, Genentech, Inc.

Thean Yeoh, Ph.D., Associate Research Fellow, Pfizer

Thomas A. Ciulla, M.D., MBA, Vice President, Clinical Strategy, Ophthotech

Thomas J. Gardella, Ph.D., Associate Professor, Medicine, Massachusetts General Hospital, Harvard

Thomas M.Frimurer, Ph.D., Associate Professor, The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark

Thomas Roddy, Ph.D., Senior Director, Cellular Metabolism, Agios Pharmaceuticals, Inc.

Thorsten Gantke, Ph.D., Project Leader, Affimed

Tillmann Michels, Head of Research Group, Immune Checkpoint Inhibitors, Department of Interventional Immunology, Regensburg Center for Interventional Immunology; Member, Department of Translational Immunology, German Cancer Research Center

Tim Kaminski, Ph.D., Postdoctoral Fellow, Biophysics/Discovery Sciences, AstraZeneca

Timothy A. McKinsey, Ph.D., Associate Professor and Associate Division Head for Translational Research, and Director, Consortium for Fibrosis Research and Translation, Department of Medicine, Division of Cardiology, University of Colorado Denver

TJ Cradick , Ph.D., Head of Genome Editing, CRISPR Therapeutics

Tony Kossiakoff, Ph.D., Professor, Biochemistry, Molecular Biology and the Institute for Biophysical Dynamics, University of Chicago

Tso Pang Yao, Ph.D., Professor of Pharmacology and Cancer Biology and Associate Professor of Radiation Oncology, Duke University School of Medicine

Udo Oppermann, Ph.D., Professor, Molecular Biology; Director, Molecular Laboratory Sciences, Botnar Research Centre; Principal Investigator, Epigenetics and Metabolism, Structural Genomics Consortium, University of Oxford

Veronique Lecault, Ph.D., Co-Founder, AbCellera

Vidya Kunjathoor, Ph.D., Scientist, Cardiovascular & Metabolic Disease Area, Novartis Institutes for BioMedical Research, Inc.

Vinit Mahajan, M.D., Ph.D., Assistant Professor of Ophthalmology and Visual Sciences, University of Iowa College of Medicine

Wade Blair, Ph.D., Executive Director, Infectious Disease and Vaccines, Merck

Ward Peterson, Founder & CEO, Symberix, Inc.

Wayne W. Hancock, M.D., Ph.D., Professor of Pathology and Chief of Transplant Immunology, Children’s Hospital of Philadelphia and University of Pennsylvania

Weilin Xie, Ph.D., Senior Principal Scientist, Biotherapeutics, Celgene Corp.

William Harriman, Ph.D., MBA, CSO, Crystal Bioscience

Xiaodong Cheng, Ph.D., Professor, Department of Biochemistry, Emory University

Xiaokui Zhang, Ph.D., Director, Research & Development, Celgene Cellular Therapeutics

Xin Huang, Ph.D., Principal Scientist and Group Leader, Molecular Engineering, Amgen

Yael Schwartz, Ph.D., CEO, Or-Genix Therapeutics, Inc.

Yejing Ge, Ph.D., Postdoctoral Fellow, Laboratory of Dr. Elaine Fuchs, Department of Mammalian Cell Biology and Development, Rockefeller University

Yingnan Zhang, Ph.D., Scientific Manager, Department of Early Discovery Biochemistry, Genentech

Yongcheng Song, Ph.D., Associate Professor, Department of Pharmacology, Baylor College of Medicine

Yusheng Xiong, Ph.D., Director, Exploratory Chemistry, Merck Research Laboratories

Zain Kassam, M.D., MPH, FRCPC, CMO, OpenBiome; Gastroenterologist, Epidemiologist and Research Affiliate, MIT Center for Microbiome Informatics & Therapeutics